WELCOME TO The chemical REPORT
Austin Chemical Company, Inc
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
PRODUCTS AND TECHNOLOGIES
H.I.G. Capital | November 02, 2021
H.I.G. Capital a leading global alternative investment firm with over $45 billion of equity capital under management, announced today that its portfolio company, USALCO, LLC (“USALCO”), has completed a merger with G2O Technologies LLC (“G2O”), a portfolio company of Arsenal Capital Partners (“Arsenal”). Ken Gayer, the current USALCO CEO, will lead the new company which will continue to bear the name USALCO
The USALCO and G2O merger creates one o...
Prnewswire | October 09, 2020
Patients who recovered from COVID-19 at St. Luke's University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans. The "convalescent plasma" was separated from the survivors' blood and is being studied as part of a research project labeled AR-701, sponsored by Aridis Pharmaceuticals, a biopharmaceutical firm in San Jose, Ca., th...
Air Liquide, BASF | November 22, 2021
Air Liquide and BASF are planning to develop the world’s largest cross-border Carbon Capture and Storage (CCS) value chain. The goal is to significantly reduce CO2 emissions at the industrial cluster in the port of Antwerp. The joint project “Kairos@C” has been selected for funding by the European Commission through its Innovation Fund, as one of the seven large-scale projects out of more than 300 applications.
Kairos@C will be jointly developed by Air Liquide an...
Sciencedaily | August 11, 2020
The enzymes responsible for catalytic reactions in our body's biological reactions are difficult to use for diagnosis or treatment as they react only to certain molecules or have low stability. Many researchers anticipate that if these issues are ameliorated or if artificial catalysts are developed to create a synergetic effect by meeting the enzymes in the body, there will be new ways to diagnose and treat diseases. In particular, if artificial catalysts that respond to external stimuli suc...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE